ECMO
16
6
7
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 16 trials
100.0%
+13.5% vs benchmark
6%
1 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (16)
Standby Cannulated ECMO for High-Risk Percutaneous Coronary Intervention
Influence of Personalized Lung Volume Optimization Maneuver on Lung Function and Cardiac Performance in Children
Early Intra-aortic Balloon Pump Use After Venoarterial Extracorporeal Membrane Oxygenation
Veno-venous Extracorporeal Membrane Oxygenation (VV-ECMO) Heparin Study
Effect of Initiation of Veno-venous ECMO on Urine Output and Acute Kidney Injury
EVOLUTION OF D-DIMER AS A MARKER OF BLEEDING RISK ON ECMO
Virtual Reality Training for ECMO Circuit Checks
Restrictive Versus Liberal Thresholds for RBC Transfusion in ECMO
A Novel Strategy of ECMO Management Using Nafamostat for Regional Combined With Low Intensity Systematic Anticoagulation
The ECMOCYP (cytochromes P450 Activity) Study
To Construct a Prognosis Prediction Model for ECMO Patients Based on Machine Learning Algorithms
Precise Treatment of Ceftazidime-Avibactam in Patients With CRO Infections Under the Guidance of TDM and PPK Model
Can Blood Panels Provide Early Warning of Bleeding in Patients on ECMO?
Effects of Ulinastatin on Inflammatory Response During ECMO Support
Cardinality Matching Study of Early v.s. Delayed VV ECMO in Severe Respiratory Failure
Safety and Effectiveness of Low-flow ECMO Driving by CVVH Machine in Severe NCP